Miaomiao Li

Miaomiao Li


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2023 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
HCHongli Chen
Hongli Chen
JHJingjing Hao
Jingjing Hao
JHJing Hu
Jing Hu
CSChang Song
Chang Song
YZYesheng Zhou
Yesheng Zhou
HXHui Xing
Hui Xing
Background: Emerging HIV drug resistance caused by increased usage of antiretroviral drugs (ARV) could jeopardize the success of standardized HIV management protocols in resource-limited settings. Objective: We aimed to characterize pretreatment HIV drug resistance (PDR) among HIV-positive individuals and risk factors in China in 2022. Methods: This cross-sectional study was conducted using 2-stage systematic sampling according to the World Health Organization’s surveillance guidelines in 8 provincial-level administrative divisions in 2022. Demographic information and plasma samples were obtained from study participants. PDR was analyzed using the Stanford HIV drug resistance database, and the Tamura-Nei 93 model in HIV-TRACE was used to calculate pairwise matches with a genetic distance of 0.01 substitutions per site. Logistic regression was used to identify and estimate factors associated with PDR. Results: PDR testing was conducted on 2568 participants in 2022. Of the participants, 34.8% (n=893) were aged 30-49 years, 81.4% (n=2091) were male, and 3.2% (n=81) had prior ARV exposure. The prevalence of PDR to protease and reverse transcriptase regions, nonnucleoside reverse transcriptase inhibitors, nucleoside reverse transcriptase inhibitors, and protease inhibitors were 7.4% (n=190), 6.3% (n=163), 1.2% (n=32), and 0.2% (n=5), respectively. Yunnan, Jilin, and Zhejiang had much higher PDR incidence than did Sichuan. The prevalence of nonnucleoside reverse transcriptase inhibitor–related drug resistance was 6.1% (n=157) for efavirenz and 6.3% (n=163) for nevirapine. Multivariable logistic regression models indicated that participants who had prior ARV exposure (odds ratio [OR] 7.45, 95% CI 4.50-12.34) and the CRF55_01B HIV subtype (OR 2.61, 95% CI 1.41-4.83) were significantly associated with PDR. Among 618 (24.2%) sequences (nodes) associated with 253 molecular transmission clusters (size range 2-13), drug resistance mutation sites included K103, E138, V179, P225, V106, V108, L210, T215, P225, K238, and A98. Conclusions: The overall prevalence of PDR in China in 2022 was modest. Targeted genotypic PDR testing and medication compliance interventions must be urgently expanded to address PDR among newly diagnosed people living with HIV in China.

1 July 2018 in Thrombosis Research
Verified
Journal Article
Closed access
MLMiaomiao Li
Miaomiao Li
Valerio De StefanoValerio De Stefano
Valerio De Stefano
TSTingxue Song
Tingxue Song
XZXinmiao Zhou
Xinmiao Zhou
ZGZeqi Guo
Zeqi Guo
XQXingshun Qi
Xingshun Qi

5 April 2025 in Pediatric Research
Verified
Journal Article
Open access
PDF file
RXRongfang Xie
Rongfang Xie
ZTZhujue Taohuang
Zhujue Taohuang
RKRosalind Kieran
Rosalind Kieran
ZLZhiyu Li
Zhiyu Li
LWLuying Wang
Luying Wang
MLMiaomiao Li
Miaomiao Li
Background: Infantile hemangiomas (IH) are common vascular tumors in infants, with no well-defined therapeutic agents currently available. Recent studies have explored molecular mechanisms involved in IH progression, but the lack of immortalized hemangioma-derived endothelial cell (iHemEC) models has limited drug discovery efforts. Methods: We established an immortalized hemangioma-derived endothelial cell (iHemEC) expressing hemangioma markers and screened 18 potential drugs. Transcriptome profiling and Gene Set Enrichment Analysis (GSEA) were applied to assess the molecular effects of Everolimus and Sunitinib. Results: Sunitinib, Elimusertib, HIF-1 inhibitor-4, Rebastinib, and Everolimus inhibited iHemEC with lower IC 50 than Propranolol and Rapamycin. GSEA showed that PI3K/AKT/mTOR pathway was only downregulated in Everolimus treated cells. Chromosome instability was found specifically in Sunitinib treated cells, which has been reported to cause DNA damage. DNA damage induced ROS and extracellular ROS production was only observed in Sunitinib treated cells. Additionally, Sunitinib can trigger P53 activation and BCL2 downregulation with a dose of 0.2 µM which is fifty times lower than the dose of Everolimus at 10 µM. Conclusion: We successfully developed an iHemEC model for in vitro drug screening and mechanistic study. Everolimus and Sunitinib emerged as promising therapeutic candidates for IH, providing a valuable basis for future research. Clinical perspectives: Infantile hemangiomas (IH) are very common tumors in the neonatal period, with an incidence of approximately 2% to 10% among newborns, there are no well-defined therapeutic agents for IH, nor are there established human immortalized cell lines for in vitro studies. We establish an immortalized hemangioma-derived endothelial cell (iHemEC) which highly express markers of hemangioma. Drug screening was performed on iHemEC, Everolimus and Sunitinib were found efficiently induce cell death to iHemEC with much lower IC 50 than front line drug Propranolol. Bulk RNAseq and WB analysis showed that Everolimus specifically inhibit PI3K/AKT/mTOR pathway, however Sunitinib induce chromosome instability and DNA damage. Both drugs can trigger P53 dependent cell death. Our study successfully developed an iHemEC cell line suitable for in vitro drug screening and mechanistic study. Sunitinib, VEGFR inhibitor, potentially can applied for the treatment of IH. Impact: Developed a novel immortalized hemangioma-derived endothelial cell (iHemEC) model that replicates key IH features, overcoming limitations of primary cell models. Identified Sunitinib and Everolimus as promising therapeutic candidates with superior efficacy, supported by transcriptome and protein analyses. Revealed distinct drug mechanisms, with Everolimus targeting PI3K/AKT/mTOR and Sunitinib inducing chromosome instability and DNA damage.

21 November 2021 in Women & Health
Verified
Journal Article
Closed access
NZNingzhi Zhang
Ningzhi Zhang
LMLi Mei
Li Mei
MLMin LI
Min LI
YZYanjun Zhang
Yanjun Zhang
JXJinliang Xu
Jinliang Xu
YGYeqing Gu
Yeqing Gu
Iron deficiency anemia (IDA) in pregnant women was associated with increased risks of both maternal and neonatal adverse outcomes. This study aimed to investigate the prevalence of IDA and identify the associated factors of IDA among pregnancy woman in Fuyang, China. The cross-sectional study was carried out in 789 pregnant women using simple random sampling method living in Fuyang, China from August 2017 to May 2018. Overall, the prevalence of IDA was 39.8%. 1-unit increment in maternal age was associated with a 5% increased risk of IDA, and 1-unit increased in BMI was associated with a 6% decreased risk of IDA (all P < .01). When compared with exercise for <30 minutes, 30–60 minutes of daily exercise was associated with a lower risk of IDA (P = .02). Similarly, when compared with a low frequency intake of iron-rich food, intake≥once/week was associated with a lower risk of IDA (P < .0001). However, vitamin C-rich food intake ≥twice/day was associated with a higher risk of IDA (P = .01) and a normal or bad appetite increased the risk of IDA when compared with a good appetite (P < .01). Our findings suggested that high frequency of iron-rich food intake, good appetite, and moderate physical activity were important for the prevention of IDA during pregnancy.

12 January 2025 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
RXRongfang Xie
Rongfang Xie
MLMiaomiao Li
Miaomiao Li
Xusheng WangXusheng Wang
Xusheng Wang
ZLZhongjie Liu
Zhongjie Liu
Hair follicle (HF) development and pigmentation are complex processes governed by various signaling pathways, such as TGF-β and FGF signaling pathways. Nestin + (neural crest like) stem cells are also expressed in HF stem cells, particularly in the bulge and dermal papilla region. However, the specific role and differentiation potential of these Nestin-positive cells within the HF remain unclear, especially regarding their contribution to melanocyte formation and hair pigmentation. Bone morphogenetic protein 4 (BMP4), members of the TGFβ family, has been implicated in regulating HF growth, coloration, and related cellular behaviors. Its role in directing Nestin-positive cells toward a melanocytic lineage has yet to be fully explored. In this study, mouse HF organoids were constructed and shown to be an ideal model for studying HF growth and development in vitro. Using this model as a basis, we demonstrated that BMP4 controls HF coloration as well as its length, number, and even size. Furthermore, Nestin-positive cells in the HF-especially those in the bulge region-differentiate into melanocytes, which produce the pigments that give HF its color under BMP4 stimulation. The resulting increase in pigmentation within the mouse HF organoids underscores that BMP4 has a major regulatory role in the formation of melanocytes from Nestin-positive stem cells. This research provides insights into the cellular mechanisms underlying hair pigmentation and suggests potential therapeutic applications for pigmentation disorders.

13 February 2024 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
ZSZhengwei Sun
Zhengwei Sun
MLMiaomiao Li
Miaomiao Li
CDChangxian Dong
Changxian Dong
SMShiwei Mei
Shiwei Mei
Infantile hemangioma is one of the most common benign soft tissue tumors in infants. The pathogenesis of infantile hemangioma remains unclear and twin studies regarding its incidence may help clarify disease pathogenesis. Thus, this study aimed to analyze the clinical characteristics of infantile hemangioma in twin patients and discuss its clinical incidence. We retrospectively analyzed the data of 83 pairs of twins with infantile hemangioma admitted to the Guangdong Provincial Women and Children Hospital and Henan Provincial People’s Hospital between May 2016 and May 2022. Thirty-one pairs of twins among whom both developed infantile hemangioma and 52 pairs of twins among whom only one twin was affected were included. Analysis was performed using the Spearman correlation. Additionally, we analyzed the influence of factors such as sex, twin zygosity, preterm birth, birth weight, and assisted reproduction on the clinical characteristics of twins. We observed that disease occurrence in both twins correlated with assisted reproduction (χ2 = 13. 102, P < 0.05) and preterm birth (χ2 = 36.523, P < 0.05). Twin zygosity (χ2 = 0.716, P > 0.05) and total birth weight of twins (t=-3.369, P > 0.05) were not correlated with infantile hemangioma. However, among twins, the ones with lesser birth weight were more likely to develop infantile hemangioma. The clinical characteristics of infantile hemangioma in twins were consistent with their epidemiological characteristics. Female sex, preterm birth, less birth weight, and assisted reproduction increased the probability of morbidity in both twins. Analysis of the characteristics of infantile hemangioma in twins may assist further research and clinical treatment.